RxDoctor Payments Data

Sumit Parikh, MD

Neurology with Special Qualifications in Child Neurology · Cleveland, OHNPI 1598863797

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,360 of the $3,360 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, UCB SA.

$3,360in general payments, 2019–2025

Across 2 payments — averaging $1680.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB SA$3K
$490,915in research payments, 2019–2025

Across 68 payments — averaging $7219.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astellas Pharma Inc$236K
  • Acadia Pharmaceuticals Inc$227K
  • PTC Therapeutics, Inc.$29K

What the payments were for

  • Consulting fees$3,360100%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB SA2$3,360

How this compares

$3,360 in reported general payments places this provider in the 60th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$2,686
Medicare patients
18
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DaybueTrofinetide12$457,681
Leucovorin Calcium28$16,543
TegretolCarbamazepine11$2,258
LevocarnitineLevocarnitine (With Sugar)13$2,249
Levocarnitine11$1,193
Carbidopa-LevodopaCarbidopa/Levodopa14$578
Baclofen13$302
Topiramate14$43

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →